I26.99

Other pulmonary embolism without acute cor pulmonale

## Overview of Other Pulmonary Embolism without Acute Cor Pulmonale Other pulmonary embolism (PE) without acute cor pulmonale, coded as I26.99 in ICD-10, refers to the obstruction of one or more pulmonary arteries by various substances (other than a typical thrombotic embolus, or when the specific type of embolus is not otherwise classified) without leading to acute right-sided heart failure. This diagnosis encompasses non-specific or less common forms of pulmonary embolism where the impact on the right ventricle is not severe enough to cause acute cor pulmonale. While most PEs are thrombotic (blood clots), 'other' can refer to fat embolism, air embolism, tumor embolism, amniotic fluid embolism, foreign body embolism, or septic embolism not specifically coded elsewhere, provided they do not result in acute right heart strain. ### Pathophysiology The underlying mechanism involves the migration of embolic material from a peripheral site into the pulmonary arterial system. This material lodges in the pulmonary arteries, leading to a reduction in the cross-sectional area of the pulmonary vascular bed. The severity of obstruction determines the physiological consequences. When the obstruction is significant, it increases pulmonary vascular resistance, which in turn elevates the afterload on the right ventricle. The right ventricle, unaccustomed to high pressures, can fail, leading to acute cor pulmonale. In the case of I26.99, the embolic burden is either smaller, involves less critical vessels, or the patient's cardiopulmonary reserve is sufficient to prevent acute right ventricular dysfunction. The 'other' aspect implies the embolic material may be diverse: a fat embolus can arise from long bone fractures; an air embolus from central venous catheter insertion or surgery; a tumor embolus from malignant neoplasms; or a septic embolus from an infective endocarditis or deep-seated infection. Regardless of the material, the ultimate effect is ventilation-perfusion mismatch, increased dead space, bronchoconstriction, and potentially pulmonary infarction, all contributing to impaired gas exchange. The absence of acute cor pulmonale differentiates this from more severe, life-threatening PEs (I26.0). ### Clinical Presentation Patients with other pulmonary embolism without acute cor pulmonale typically present with symptoms reflective of pulmonary artery obstruction and associated inflammation, but without overt signs of right heart failure (e.g., hypotension, syncope, jugular venous distention). Common symptoms include sudden onset dyspnea, pleuritic chest pain (pain worsens with inspiration), cough, and sometimes hemoptysis. Tachycardia and tachypnea are frequently observed. Less common presentations can include unexplained anxiety or feeling of impending doom. The specific symptoms can vary depending on the size and location of the embolus. For instance, a small peripheral embolism might cause only mild pleuritic pain, whereas a larger, but still non-cor pulmonale-inducing, embolus could cause more pronounced dyspnea. Physical examination might reveal clear lung sounds or localized crackles, and signs of deep vein thrombosis (DVT) in the legs (swelling, tenderness, erythema), though not always present or directly related in non-thrombotic cases. ### Diagnostic Criteria Diagnosis begins with clinical suspicion, often guided by risk factor assessment and symptom presentation. Initial tests typically include D-dimer, which if negative in a low-probability patient, can rule out PE. However, D-dimer is often elevated in various conditions, so a positive result necessitates further investigation. Electrocardiogram (ECG) might show sinus tachycardia, T-wave inversions in V1-V3, or S1Q3T3 pattern (though less common without acute cor pulmonale). Arterial blood gas (ABG) may show hypoxemia and respiratory alkalosis. The gold standard for diagnosis is computed tomography pulmonary angiography (CTPA), which directly visualizes emboli within the pulmonary arteries. Other diagnostic modalities include ventilation-perfusion (V/Q) scans, particularly useful in patients with renal impairment or contrast allergies, and lower extremity venous ultrasound to detect DVT. Echocardiography might be performed to assess right ventricular function, specifically looking for signs of strain that would indicate acute cor pulmonale (which should be absent in I26.99). ### Standard of Care The management of pulmonary embolism without acute cor pulmonale primarily focuses on anticoagulation to prevent further clot formation and allow endogenous fibrinolysis to dissolve existing emboli. This typically involves immediate initiation of parenteral anticoagulants (e.g., unfractionated heparin, low molecular weight heparin, fondaparinux) followed by oral anticoagulation, often with direct oral anticoagulants (DOACs) like rivaroxaban, apixaban, edoxaban, or dabigatran, or vitamin K antagonists like warfarin. The duration of anticoagulation varies based on the underlying cause and risk of recurrence, usually for a minimum of 3 months. For 'other' types of embolism (e.g., fat, air, tumor), management often includes addressing the underlying cause. For example, treating the fracture in fat embolism, or source control in septic embolism. Thrombolysis is generally reserved for hemodynamically unstable patients or those with acute cor pulmonale and is typically not indicated for I26.99. Supportive care, including oxygen therapy, analgesia, and close monitoring, is also crucial. Prevention of recurrence involves identifying and mitigating risk factors, and long-term anticoagulation in selected cases.

Clinical Symptoms

  • Sudden onset dyspnea
  • Pleuritic chest pain
  • Cough
  • Tachypnea
  • Tachycardia
  • Hemoptysis (less common)
  • Unexplained anxiety
  • Feeling of impending doom
  • Localized crackles (on lung auscultation)
  • Mild fever

Common Causes

  • Deep vein thrombosis (DVT) (most common underlying cause for thrombotic PE, though 'other' implies non-thrombotic often)
  • Fat embolism (e.g., from long bone fractures, orthopedic surgery)
  • Air embolism (e.g., from central venous catheter insertion, lung biopsy, surgery, trauma)
  • Tumor embolism (e.g., from renal cell carcinoma, hepatic carcinoma, choriocarcinoma)
  • Amniotic fluid embolism (rare, occurs during labor or immediately postpartum)
  • Foreign body embolism (e.g., IV drug use, broken catheter fragments)
  • Septic embolism (e.g., from infective endocarditis, deep-seated abscesses, osteomyelitis)
  • Hypercoagulable states (though more related to thrombotic PE, underlying predisposition can lead to atypical clots)
  • Immobility/prolonged bed rest
  • Recent surgery (especially orthopedic)
  • Trauma
  • Obesity
  • Cancer
  • Estrogen-containing medications (oral contraceptives, hormone replacement therapy)

Documentation & Coding Tips

Always specify the acuity of the pulmonary embolism (PE) and explicitly state the absence or presence of acute cor pulmonale. For I26.99, it is critical to confirm 'without acute cor pulmonale'.

Example: ACUTE PULMONARY EMBOLISM: Patient presents with acute onset dyspnea and pleuritic chest pain. CTA chest confirms bilateral segmental and subsegmental pulmonary emboli. Echocardiogram shows normal right ventricular function with no evidence of acute right heart strain or cor pulmonale. Patient is hemodynamically stable. Diagnosed as acute pulmonary embolism, without acute cor pulmonale. Plan: Initiate therapeutic anticoagulation with Apixaban 10mg BID for 7 days, then 5mg BID. Patient has a history of Factor V Leiden mutation (HCC: D68.51), a significant risk factor for VTE, which is being managed. This underlying hypercoagulable state increases the overall risk adjustment factor.

Billing Focus: Explicitly stating 'acute' and 'without acute cor pulmonale' supports I26.99. Detailed imaging findings (segmental, subsegmental, bilateral) provide clinical specificity. Documentation of anticoagulation initiation supports medical necessity.

Document the likely source of the pulmonary embolism, particularly deep vein thrombosis (DVT), and specify its location and laterality.

Example: PULMONARY EMBOLISM (ACUTE, WITHOUT ACUTE COR PULMONALE): Patient admitted with dyspnea. CTA chest positive for PE. Lower extremity duplex ultrasound performed, revealing acute deep vein thrombosis in the right common femoral and popliteal veins. Patient also has history of recent right total knee arthroplasty (Z98.818) 3 weeks ago, a contributing factor. No signs of RV dysfunction on echo. Plan: Continue therapeutic enoxaparin bridging to warfarin. INR monitoring initiated. Right lower extremity DVT is the probable source of the PE.

Billing Focus: Documenting the associated DVT (e.g., I82.411 - Acute embolism and thrombosis of right femoral vein) provides crucial context and allows for co-occurrence coding. Specifying laterality (right) and the specific veins (common femoral, popliteal) is essential for accurate DVT coding. The recent surgery (Z98.818) provides a valuable causal link.

Detail all contributing risk factors and comorbidities that led to the PE. This provides medical necessity and supports comprehensive risk adjustment.

Example: FOLLOW-UP, PULMONARY EMBOLISM: Patient returning for follow-up of PE diagnosed 2 months ago, currently stable on Rivaroxaban. Initial PE was secondary to prolonged immobilization following a fractured left ankle (S82.312A) requiring ORIF. Other pertinent history includes obesity (BMI 35.2, E66.9) and controlled hypertension (I10). No residual dyspnea. Echocardiogram reveals resolved RV strain. Patient counseled on adherence to anticoagulation and importance of ambulation. The obesity is a chronic condition contributing to overall risk.

Billing Focus: Explicitly linking the immobilization from the fractured ankle (S82.312A for fracture, Z99.3 for dependence on wheelchair if applicable, or Z91.89 for other specified personal risk factors) as a contributing factor strengthens the clinical narrative and medical necessity. Documenting chronic conditions like obesity (E66.9) and hypertension (I10) is vital.

Document the patient's clinical stability and the absence of complications such as acute cor pulmonale or hemodynamic instability.

Example: ED VISIT: 58 y/o female presenting with sudden onset shortness of breath and mild chest discomfort. ECG with sinus tachycardia. Troponins negative. CTA chest reveals small, subsegmental PE in the right lower lobe. Patient is afebrile, normotensive (BP 120/70), O2 saturation 96% on room air. No elevated JVP, no peripheral edema. Echo shows preserved RV function, no signs of acute cor pulmonale. PESI score 65 (low risk). Discharged home on Apixaban with strict follow-up instructions. The small, subsegmental nature and hemodynamic stability confirm 'without acute cor pulmonale'.

Billing Focus: Describing the PE as 'small, subsegmental' and explicitly noting the patient's hemodynamic stability (BP, O2 sat, absence of JVP/edema) and normal RV function on echo directly supports the 'without acute cor pulmonale' component of I26.99. The low PESI score reinforces the non-massive nature, impacting resource utilization.

Clearly outline the management plan, including specific anticoagulation regimens, duration, and any monitoring required.

Example: HOSPITAL COURSE: Patient with acute submassive PE without acute cor pulmonale. Initially started on IV unfractionated heparin, transitioned to oral Edoxaban 60mg daily. Renal function monitored (CrCl > 50 mL/min). Patient tolerated medication well, no bleeding complications. Ambulating without dyspnea. Follow-up plan includes 3 months of Edoxaban therapy, with reassessment for extended duration. Cardiology consult recommended for long-term anticoagulation management strategy.

Billing Focus: Specific medication names (e.g., Edoxaban), dosage, and duration of therapy (3 months) provide concrete evidence of active management. Documenting monitoring (renal function) supports the complexity of care. 'Submassive PE without acute cor pulmonale' is a precise description.

Relevant CPT Codes

Related Diagnoses

Hierarchy